Affimed N.V. (LON:0HL9)
London · Delayed Price · Currency is GBP · Price in USD 0.0001
0.00 (0.00%)
Feb 12, 2026, 2:35 PM GMT
Affimed Market Cap
Affimed has a market cap or net worth of 1.2 thousand as of February 12, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
1.20K
Enterprise Value
-9.18M
Revenue
4.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since September 12, 2014, Affimed's market cap has decreased from 136.71M to 1.20K, a decrease of -100.00%. That is a compound annual growth rate of -63.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.20K | -1.36% |
| Dec 31, 2025 | 1.22K | -99.99% |
| Dec 31, 2024 | 15.58M | -78.74% |
| Dec 29, 2023 | 73.28M | -52.32% |
| Dec 30, 2022 | 153.69M | -69.37% |
| Dec 31, 2021 | 501.82M | 19.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| ValiRx | 2.45M |
| BSF Enterprise | 2.31M |
| Roquefort Therapeutics | 1.80M |
| Physiomics | 1.44M |